Skip to contentTAGLICH MICHAEL N — Gales Industries Inc insider: 1,092 transactions · InsiderLensTAGLICH MICHAEL N
- Director at SCOLR Pharma, Inc. · on record since Jan 5, 2006
- Director at INTELLINETICS, INC. · on record since Jan 4, 2024
- Former Director at DecisionPoint Systems, Inc. · on record since Jul 9, 2024
- Director at Gales Industries Inc · on record since Oct 16, 2008
- Director at INTERFERON SCIENCES INC · on record since Aug 25, 2003
- Director at WSI INDUSTRIES, INC. · on record since Dec 11, 2003
- Director at Bridgeline Software, Inc. · on record since Nov 8, 2013
- Director at Caldera Pharmaceuticals Inc · on record since Jun 3, 2013
- Director at DecisionPoint Systems, Inc. · on record since Jan 29, 2015
- 10% owner at Caldera Pharmaceuticals Inc · on record since Jan 9, 2015
- 10% owner at INTELLINETICS, INC. · on record since Apr 29, 2015
- 10% owner at Bridgeline Software, Inc. · on record since Jul 23, 2015
- 10% owner at Gales Industries Inc · on record since Sep 19, 2016
- 10% owner at DecisionPoint Systems, Inc. · on record since May 20, 2022
Insider trading activity of TAGLICH MICHAEL N
- Transactions on record
- 1,092
- since Oct 3, 2003
- Open-market buys
- 53
- $2.9M
- Open-market sells
- 10
- $876.2K
- Companies traded
- 8
- last filing Jun 30, 2026
Figures computed from official regulatory filings — methodology.
Companies where TAGLICH MICHAEL N has traded
- INTELLINETICS, INC.72 tx · $3.4T · Jun 30, 2026
- Gales Industries Inc785 tx · $2T · Feb 17, 2026
- Bridgeline Software, Inc.50 tx · $3.5M · Sep 3, 2024
- DecisionPoint Systems, Inc.72 tx · $11.8M · Jul 9, 2024
- Caldera Pharmaceuticals Inc50 tx · $8.3K · Aug 28, 2019
- SCOLR Pharma, Inc.47 tx · $119K · Jun 20, 2011
- WSI INDUSTRIES, INC.6 tx · Apr 21, 2004
- INTERFERON SCIENCES INC10 tx · Mar 9, 2004
Track record of TAGLICH MICHAEL N
Statistical track record
Free- Open-market buys
- 212
- Last buy
- Aug 22, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of TAGLICH MICHAEL N
Co-insiders of TAGLICH MICHAEL N
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
HOWARD DAVID TINTERFERON SCIENCES INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 30, 2026 | AwardD | 10,000 | — | — | SEC |
| Jun 18, 2026 | Sell | -3,754 | 6.58 USD | — | SEC |
| Jun 18, 2026 | Sell | -550 | 6.50 USD | — | SEC |
| Feb 17, 2026 | AwardD | 12,159 | 0.00 USD | $0 | SEC |
| Jan 21, 2026 | Other | -23,996 | 2.84 USD | $68.1K | SEC |
| Jan 21, 2026 | Other | 11,998 | 2.84 USD | $34.1K | SEC |
| Dec 9, 2025 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Oct 9, 2025 | Sell | -35,732 | 11.00 USD | $393.1K | SEC |
| Jun 25, 2025 | AwardD | 9,000 | — | — | SEC |
| Apr 23, 2025 | Award | 4,130 | 3.05 USD | $12.6K | SEC |
| Feb 4, 2025 | OtherD | -3,011 | — | — | SEC |
| Feb 4, 2025 | OtherD | -14,217 | — | — | SEC |
| Jan 8, 2025 | Award | 2,929 | 4.30 USD | $12.6K | SEC |
| Oct 8, 2024 | Award | 2,337 | 5.39 USD | $12.6K | SEC |
| Sep 17, 2024 | Sell | -7,015 | 7.00 USD | $49.1K | SEC |
| Sep 3, 2024 | Buy | 20,603 | 0.89 USD | $18.3K | SEC |
| Aug 30, 2024 | Buy | 951 | 9.00 USD | $8.6K | SEC |
| Aug 21, 2024 | AwardD | 12,000 | — | — | SEC |
| Aug 15, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jul 9, 2024 | OtherD | -6,000 | 2.46 USD | $14.8K | SEC |
| Jul 9, 2024 | Other | -831,318 | 10.22 USD | $8.5M | SEC |
| Jul 9, 2024 | OtherD | -6,000 | 3.75 USD | $22.5K | SEC |
| Jul 9, 2024 | OtherD | -6,000 | 0.94 USD | $5.6K | SEC |
| Jul 9, 2024 | OtherD | -6,000 | 6.16 USD | $37K | SEC |
| Jul 9, 2024 | OtherD | -5,000 | 8.64 USD | $43.2K | SEC |